Cyberonics publishes depression data
This article was originally published in The Gray Sheet
Executive Summary
Results from the firm's pivotal and companion studies are published in the journal Biological Psychiatry, aiding the firm's quest to secure reimbursement for VNS Therapy for treatment-resistant depression. The articles represent the same data used to support the firm's PMA submission for the device, including the firm's 235-patient, 21-site pivotal D-02 study. The firm believes that reimbursement will be in place for the therapy by 2007 (1"The Gray Sheet" July 25, 2005, p. 17)...